Great Ormond Street Hospital Skunkworks
@Omic_Research
Followers
239
Following
109
Media
72
Statuses
253
The Rare & Neurological disease NHS Skunkworks, Identifying disease mechanisms, designing new treatments & developing new tests. 'Thinking outside the box'
London, England
Joined April 2016
Our new test for measuring your antibody status. More informative and more accurate than any other test. #sarscovid2 #covid19 #covidtest #covidantibodies
0
0
0
Our latest assay that can predict long covid hits the National Press. Well done Wendy Heywood and Gaby Captur
news.sky.com
If the experimental test is validated by further research it may result in people at high risk of long-COVID being given anti-viral treatments in the hope of preventing debilitating symptoms.
0
1
0
Our latest work from the Skunk Works at GOSH/UCL. A fabulous collaboration between UCL, Imperial, Queen Mary's & Barts and DoH. A new, high throughput test for immunoprotection against Covid 19 infections. #covidtesting #newcovidtest #covidantibodies.
Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response
0
0
1
New toys arrived, look at this Shimadzu beauty!!!!
0
0
1
Our new test for covid 19. Quantitates all major antibodies . Measures neutralising capability. Gives you a readout of your protection against the different variants. Works in whole blood, serum, bloodspots, saliva and saliva 'lollipops'. Designed to work in the NHS
0
0
1
Our new test for measuring immunoprotection against SARS Covid 2. Current tests measure IgG1, ours quantitates all the major antibody and components of the immunocomplex (IgG1-4, IgA1, IgM, and the complement factors C1Q, C4b, CFB, C5, C8A and C9).
medrxiv.org
Determining the protection an individual has to SARS-CoV-2 variants of concern (VoC) will be crucial for future immune surveillance and understanding the changing immune response. As further variants...
0
0
0
Big shout out to our Skunkswork Research Group on Operation Moonshot. We did it.
linkedin.com
Some Super Heroes wear lab coats and not capes. Here are some pictures taken today of the incredible work being performed behind the scenes by the all the biochemists, clinical and research, who are...
0
0
1
We are deeply saddened to hear of the death of our UCL colleague Dr John Timms.
0
0
3
Another weekend shift for the Moonshotters
0
0
3
Our latest paper on 'Long Covid' from our Skunkworks team led by Dr Wendy Heywood. Here we show that even in people who have had a mild and even symptomless SARS Covid 2 infection, still have a inflammatory profile >40-60 days post infection.
0
0
2
Congratulations (spelt correctly) to Rob Butcher on his new appointment from all at the GOSH Skunkworks.
Congrtatulations Rob Butcher
0
0
1
Out with the old to accommodate the new, Operation Moonshot is underway. QTOF Premier you served us well from all who sailed on her. The GOSH Skunkworks goes into battle. #covid19research #moonshot #covid
0
0
3
A beautiful explanation and animation of vaccination and the process of getting the vaccination into clinical use by Simon Clark at . This is how to get science across to the masses and to get kids into science. Fabulous work.
0
0
0
Always sad when an old friend moves on, but Operation Moonshot requires levels of sensitivity we could only dream of when we bought this. Elvis served us well and we will miss him.
1
1
7
SARS COVID 2 research level = Fever Pitch.
0
0
1
This is very, very impressive .
0
0
0
Good luck to Elena Alvarez Mediavilla, our fabulous research assistant who is leaving us today. It is always sad to see a colleague leave but good luck in the future Elena .
0
0
1
Developing an antibody test for SARS Covid 2
0
0
0
Hiya everyone, I have used this absolutely fantastic Graphics Design Company in the past so please have a look. Times are hard so we all need to support these super talented people.
spystudio.co.uk
Spy is a London-based design practice founded in 2003. We create bold and effective work for an eclectic range of clients.
0
0
0
The UK higher education senior management survey: a statactivist response to managerialist governance
0
0
0